Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The societal economic value of COVID-19 vaccines in the United States
Noam Y. Kirson, Elyse Swallow, Jessica Lu, et al.
Journal of Medical Economics (2022) Vol. 25, Iss. 1, pp. 119-128
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies
Lihui Zhou, Wenxin Yan, Shu Li, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 35
Cost‐effectiveness of COVID‐19 vaccination: A systematic review
Yaqun Fu, Jingyu Zhao, Peien Han, et al.
Journal of Evidence-Based Medicine (2023) Vol. 16, Iss. 2, pp. 152-165
Open Access | Times Cited: 20
Lessons learned of COVID-19 containment policies on public health and economic growth: new perspectives to face future emergencies
Bilal Kargı, Mario Coccia
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
What Can We Learn From Responses To COVID-19 To Face The Next Pandemic Crisis? Limited Effectiveness of Stringent Restriction policies for Health and Economic Systems
Mario Coccia, Bilal Kargı
SSRN Electronic Journal (2025)
Closed Access
COVID-19 Biopharmaceutical Innovation and Industry Appropriation
Tomas Philipson, A. Mark Fendrick, Aarushi Kataria, et al.
Forum for Health Economics & Policy (2025)
Closed Access
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
Manuela Di Fusco, Kinga Marczell, Kristen A. Deger, et al.
Journal of Medical Economics (2022) Vol. 25, Iss. 1, pp. 605-617
Open Access | Times Cited: 26
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, et al.
Expert Review of Vaccines (2022) Vol. 22, Iss. 1, pp. 54-65
Open Access | Times Cited: 20
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
Moe H. Kyaw, Júlia Spinardi, Ling Zhang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States
Manuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 509-524
Open Access | Times Cited: 8
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study
Manuela Di Fusco, Diana Mendes, Lotte Steuten, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 234-234
Open Access | Times Cited: 7
The global health and economic value of COVID-19 vaccination
J.P. Sevilla, Daria Burnes, Joseph S Knee, et al.
BMJ Global Health (2024) Vol. 9, Iss. 9, pp. e015031-e015031
Open Access | Times Cited: 1
Public Health and Economic Impact of Periodic COVID-19 Vaccination with BNT162b2 for Old Adults and High-Risk Patients in an Illustrative Prefecture of Japan: A Budget Impact Analysis
Mitsuhiro Nagano, Kosuke Tanabe, Kazumasa Kamei, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 10, pp. 2155-2177
Open Access | Times Cited: 1
Willingness to receive the second booster of COVID-19 vaccine among older adults with cancer: a stratified analysis in four provinces of China
Liangyuan Zhang, Jianzhou Yang, Rila Su, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
The Effectiveness of the COVID-19 Vaccination Campaign in 2021: Inconsistency in Key Studies
Konstantin AVILOV, Wen Li, Yanji Zhao, et al.
SSRN Electronic Journal (2024)
Closed Access | Times Cited: 1
Utilisation et coûts évitables des ressources des unités de soins intensifs pour les patients non vaccinés atteints de COVID-19 : une étude de cohorte historique basée sur la population
Sean M. Bagshaw, Annalise G. Abbott, Sanjay Beesoon, et al.
Canadian Journal of Anesthesia/Journal canadien d anesthésie (2022) Vol. 69, Iss. 11, pp. 1399-1404
Open Access | Times Cited: 7
A population-based assessment of avoidable hospitalizations and resource use of non-vaccinated patients with COVID-19
Sean M. Bagshaw, Annalise G. Abbott, Sanjay Beesoon, et al.
Can J Public Health (2023) Vol. 114, Iss. 4, pp. 547-554
Open Access | Times Cited: 3
Social justice in medical education: a student-led approach to addressing COVID-19 vaccine equity in the Hispanic/Latinx community
Audrey Adler, Haley Nadone, Mirabel Dafinone, et al.
Medical Education Online (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 3
A Scoping Review on Gender/Sex Differences in COVID-19 Vaccine Intentions and Uptake in the United States
Katelyn M. Sileo, Inara M. Hirani, Rebecca Luttinen, et al.
American Journal of Health Promotion (2023) Vol. 38, Iss. 2, pp. 242-274
Open Access | Times Cited: 3
Effect of the COVID‐19 pandemic on meaningful activity engagement in racially and ethnically diverse older adults
Anna Oh, Siqi Gan, W. John Boscardin, et al.
Journal of the American Geriatrics Society (2023) Vol. 71, Iss. 9, pp. 2924-2934
Open Access | Times Cited: 2
COVID-19 vaccines should be evaluated from the societal perspective
J.P. Sevilla
Journal of Medical Economics (2023) Vol. 27, Iss. 1, pp. 1-9
Open Access | Times Cited: 2
Crafting Persuasive Stories: How Uncertainty and Sidedness Influence Narrative Efficacy in Promoting Updated COVID-19 Vaccination
Yan Huang
Science Communication (2024)
Closed Access
Watchful, skeptics, and system distrusters: Characteristics associated with different types of COVID-19 vaccine hesitancy among U.S. working-age adults
Xue Zhang, Shannon M. Monnat
Vaccine (2024) Vol. 42, Iss. 24, pp. 126080-126080
Open Access
Pharmacotherapeutic Treatment Strategies COVID-19: Lessons Learned and Perspectives
Abdurashid Khamidovich Ashirmetov
Exploratory Research and Hypothesis in Medicine (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as A Case Study
Manuela Di Fusco, Diana Mendes, Lotte Steuten, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Journal of Medical Economics in review: high impact articles from 2022
Ivo Abraham, Kenneth K.C. Lee, Mike Gregg
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 303-307
Open Access
Page 1 - Next Page

Scroll to top